Skip to main content
. 2018 May 10;2018(5):CD012069. doi: 10.1002/14651858.CD012069.pub2

Corrigall 1996.

Methods A patient report of euphoria induced by methylphenidate in an 11‐year‐old boy diagnosed with hyperkinetic disorder
Participants Diagnosis of ADHD: ICD‐10 hyperkinetic disorder
Age: 11 years old
IQ: no intellectual disability
Sex: male
Ethnicity: not stated
Country: UK
Comorbidity: not stated
Comedication: not stated
Sociodemographics: not stated
Interventions Methylphenidate 10 mg/day for 4 weeks and then increased to 15 mg/day for 5 days
Administration schedule: not stated
Duration of treatment: 6 weeks
Treatment compliance: abuse
Outcomes Non‐serious adverse events:
Methylphenidate induced euphoria on 15 mg/day. Symptoms discontinued after methylphenidate was withdrawn
Notes Ethics approval: not stated
Funding/vested interests: not stated
Authors' affiliations: Maudsley Hospital, London
Key conclusions of the study authors: euphoria induced by methylphenidate can occur in young prepubertal children and this may lead to abuse of medication
Supplemental information regarding the boys' intellectual functioning received through personal email correspondence with the authors in October 2013 (Corrigall 2013 [pers comm])